Neurointerventional Devices Market Is Growing at CAGR of 6.8% to Reach $1.7 Billion by 2017 - New Report by MarketsandMarkets

[234 Pages Report] Neurovascular/Interventional Neurology Market research report encompasses devices for neurothrombectomy (suction/aspiration devices, clot retriever and snare), cerebral balloon angioplasty & stenting systems (carotid artery stents, distal filter devices, balloon occlusion devices), aneurysm coiling & arteriovenous malformation embolization, fistula embolization devices (embolic coil, liquid embolic agents and flow diversion devices), and support devices (microcatheters, and microguidewires).

Logo

Dallas, TX -- (SBWire) -- 11/27/2013 --The “Neurovascular/Interventional Neurology Market [Aneurysm Coils, Carotid Stents, Microcatheter, Microguidewire, Liquid Embolic Agents, & Cerebral Angioplasty Balloons] – Global Trends & Competitive Analysis to 2017” analyzes and studies the major market drivers, restraints, and opportunities in Americas, Europe, Asia, and Rest of the World.

Browse 126 market data tables with 11 figures spread through 234 pages and in-depth TOC of “Neurovascular/Interventional Neurology Market"
http://www.marketsandmarkets.com/Market-Reports/neurointerventional-neurostimulation-devices-market-847.html

Early buyers will receive 10% customization on reports.
Download Free PDF @ http://www.marketsandmarkets.com/pdfdownload.asp?id=847
Request for Customization @ http://www.marketsandmarkets.com/requestCustomization.asp?id=847

This report studies the global neurointerventional devices market over the forecast period 2012-2017. The global neurointerventional devices market is estimated to be $1,248.5 million in 2012 and is expected to grow at a CAGR of 6.8% to reach $1,733.7 million by 2017.

Neurointerventional procedures refer to special kind of endovascular procedure within the vessels of the brain or within the spinal cavity, utilizing minimally invasive techniques, imaging guidance, and special microcatheters (thin tubes), guide wires, and small instruments to treat stroke and other neurological disorders. Neurointerventional procedures can be performed through different techniques such as neurothrombectomy procedure, cerebral angiography and stenting technique, and coiling procedure. These techniques are almost mutually exclusive and applied for definite clinical symptoms of neurological disorders.

The major driving factor for these markets involves gradual technological evolution, growing ageing and obese population, rising patient pool for ischemic and hemorrhagic stroke and increasing demand for minimally invasive surgical procedures. Growing GDP and healthcare allocation are making developing countries in Asia and Latin America affordable to adapt novel medical practices for obtaining better treatment outcome. Upcoming clinical trial data is favoring the interventional procedure over neurosurgery as it offers limited hospital stays, minimal damage to surrounding healthy tissues, lesser chances of infection in post-surgical phase, minimum surgical trauma and lesser surgical scar.

Gradual technological evolution, growing ageing and obese population, rising patient pool for ischemic and hemorrhagic stroke and increasing demand for minimally invasive surgical procedures are the major drivers that are slated to propel this market. Growing GDP and healthcare allocation are making developing countries in Asia and Latin America affordable to adapt novel medical practices for obtaining better treatment outcome. Upcoming clinical trial data is favoring the interventional procedure over neurosurgery as it offers limited hospital stays, minimal damage to surrounding healthy tissues, lesser chances of infection in post-surgical phase, minimum surgical trauma and lesser surgical scar.

The major players operating in the market are Covidien, PLC (Ireland), Stryker Corporation (U.S.), Johnson & Johnson (U.S.), and Penumbra, Inc. (U.S.).

Browse Related Reports
Biomarkers Market - ([Discovery Technologies - Proteomics, Genomics, Imaging, Bioinformatics], Validation Services, Applications [drug development, personalized medicine], Diseases [Oncology, Cardiology, Neurology]) - Global Trends & Forecasts (2013 – 2018)
http://www.marketsandmarkets.com/Market-Reports/biomarkers-advanced-technologies-and-global-market-43.html

Biomaterials Market [By Products (Polymers, Metals, Ceramics, Natural Biomaterials) & Applications (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Tissue Engineering, Ophthalmology, Neurology Disorders)] – Global Forecasts to 2017
http://www.marketsandmarkets.com/Market-Reports/biomaterials-393.html

About MarketsandMarkets
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, healthcare IT, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets

Media Relations Contact

Rohan Salgarkar
MARKETSANDMARKETS
888-391-5441
http://www.marketsandmarkets.com/

View this press release online at: http://rwire.com/395774